Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 47 | 0 | 5 | 0 | €681.50 | €753.63 | 10.584% |
Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | €370.20 | €382.71 | 3.378% |
Boston Scientific | 37 | 0 | 4 | 0 | €63.50 | €61.53 | -3.109% |
Intuitive Surgical Inc | 35 | 0 | 3 | 0 | €343.70 | €368.20 | 7.128% |
UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €470.35 | €543.72 | 15.599% |
Johnson & Johnson | 32 | 1 | 2 | 1 | €138.82 | €196.74 | 41.720% |
Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €841.20 | €954.29 | 13.444% |
Merck & Co. Inc. | 27 | 1 | 4 | 0 | €118.20 | €124.92 | 5.681% |
Thermo Fisher Scientific Inc. | 24 | 0 | 3 | 0 | €511.40 | €561.51 | 9.798% |
Amgen Inc. | 23 | 0 | 3 | 0 | €252.45 | €293.65 | 16.319% |
Edwards Lifesciences Corp. | 24 | 1 | 4 | 0 | €80.64 | €87.81 | 8.887% |
Humana Inc. | 20 | 0 | 3 | 0 | €308.10 | €473.29 | 53.614% |
HCA Holdings Inc. | 19 | 0 | 2 | 0 | €286.50 | €289.63 | 1.091% |
BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €84.64 | €102.48 | 21.073% |
Abbott Laboratories | 18 | 1 | 3 | 0 | €100.70 | €116.71 | 15.902% |
AbbVie Inc. | 18 | 1 | 3 | 1 | €156.20 | €175.79 | 12.540% |
Stryker Corp. | 17 | 0 | 4 | 0 | €305.40 | €331.52 | 8.554% |
Dexcom Inc. | 17 | 0 | 2 | 0 | €122.72 | €136.81 | 11.482% |
Resmed Inc. | 16 | 0 | 2 | 0 | €167.90 | €189.13 | 12.646% |
Novo Nordisk A/S ADR | 17 | 1 | 5 | 0 | €115.50 | €130.00 | 12.554% |
Cigna Corp. | 15 | 0 | 1 | 0 | €330.85 | €342.03 | 3.379% |
Agilent Technologies Inc. | 17 | 3 | 2 | 1 | €124.56 | €133.66 | 7.306% |
Centene Corp. | 13 | 0 | 5 | 0 | €70.55 | €82.26 | 16.592% |
Hologic Inc. | 13 | 0 | 2 | 0 | €71.00 | €84.03 | 18.355% |
Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 1 | 0 | €12.10 | €13.50 | 11.570% |